TherOx, a privately held medical device company based in Irvine, Calif., is focused on developing and commercializing its SuperSaturated Oxygen Therapy to treat ischemic tissues and conditions. Using the TherOx technology, hyperbaric levels of oxygen can be delivered to the heart to salvage tissue affected by acute myocardial infarction. This is the first of many applications for TherOx’s technology platform.